Condensed Consolidated Statements of Stockholders Equity (Deficit) - USD ($) $ in Thousands	Previously Reported Convertible Preferred Stock	Previously Reported Common Stock	Previously Reported Additional Paid-In Capital	Previously Reported Accumulated Other Comprehensive (Loss)	Previously Reported Accumulated Deficit	Previously Reported	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive (Loss)	Accumulated Deficit	Total
Retroactive application of reverse capitalization (Note 3)	$ (51,452)	$ 1	$ 51,451			$ 51,452
Retroactive application of reverse capitalization (Note 3) (in shares)	(12,075,976)	6,636,983
Balance at Dec. 31, 2021	$ 51,452		94,894		$ (166,126)	(71,232)	$ 1	$ 146,345		$ (166,126)	$ (19,780)
Balance (in shares) at Dec. 31, 2021	12,075,976	2,185,297					8,822,280
Stock-based compensation								70			70
Exercise of stock options								25			25
Exercise of stock options (in shares)							5,696
Exercise of warrants								230			230
Exercise of warrants (in shares)							68,588
Proceeds from private placement								25,262			25,262
Proceeds from private placement (in shares)							1,240,169
Net loss										(5,729)	(5,729)
Balance at Mar. 31, 2022							$ 1	171,932		(171,855)	78
Balance (in Shares) at Mar. 31, 2022							10,136,733
Balance at Dec. 31, 2021	$ 51,452		94,894		(166,126)	(71,232)	$ 1	146,345		(166,126)	(19,780)
Balance (in shares) at Dec. 31, 2021	12,075,976	2,185,297					8,822,280
Net loss											(13,576)
Balance at Jun. 30, 2022							$ 2	249,206		(179,702)	69,506
Balance (in Shares) at Jun. 30, 2022							20,187,140
Balance at Mar. 31, 2022							$ 1	171,932		(171,855)	78
Balance (in shares) at Mar. 31, 2022							10,136,733
Stock-based compensation								219			219
Exercise of stock options								92			92
Exercise of stock options (in shares)							21,442
Exercise of warrants								(151)			(151)
Exercise of warrants (in shares)							4,650
Proceeds from private placement							$ 1	76,392			76,393
Proceeds from private placement (in shares)							10,015,015
Shares issued pursuant to consulting agreement								38			38
Issuance of warrants pursuant to debt financing								178			178
Issuance of warrants pursuant to debt financing (in shares)							9,300
Other								506			506
Net loss										(7,847)	(7,847)
Balance at Jun. 30, 2022							$ 2	249,206		(179,702)	69,506
Balance (in Shares) at Jun. 30, 2022							20,187,140
Retroactive application of reverse capitalization (Note 3)	$ (165,923)	$ 2	165,921			165,923
Retroactive application of reverse capitalization (Note 3) (in shares)	(35,694,179)	17,665,636
Balance at Dec. 31, 2022	$ 165,923		86,353	$ (8)	(199,734)	(113,389)	$ 2	252,274	$ (8)	(199,734)	52,534
Balance (in shares) at Dec. 31, 2022	35,694,179	2,522,214					20,187,850
Effect of Merger and recapitalization (refer to Note 3)							$ 1	54,301			54,302
Effect of Merger and recapitalization (refer to Note 3) (in shares)							11,422,741
Reclassification of Legacy Orchestra common stock warrants to stockholders' equity								2,373			2,373
Unrealized loss on marketable securities									(27)		(27)
Stock-based compensation								1,489			1,489
Exercise of stock options								10			10
Exercise of stock options (in shares)							2,325
Exercise of warrants								11			11
Exercise of warrants (in shares)							128,231
Net loss										(10,940)	(10,940)
Balance at Mar. 31, 2023							$ 3	310,458	(35)	(210,674)	99,752
Balance (in Shares) at Mar. 31, 2023							31,741,147
Balance at Dec. 31, 2022	$ 165,923		$ 86,353	$ (8)	$ (199,734)	$ (113,389)	$ 2	252,274	(8)	(199,734)	52,534
Balance (in shares) at Dec. 31, 2022	35,694,179	2,522,214					20,187,850
Unrealized loss on marketable securities											(88)
Net loss											(22,986)
Balance at Jun. 30, 2023							$ 4	312,251	(96)	(222,720)	89,439
Balance (in Shares) at Jun. 30, 2023							35,743,007
Balance at Mar. 31, 2023							$ 3	310,458	(35)	(210,674)	99,752
Balance (in shares) at Mar. 31, 2023							31,741,147
Issuance of shares in settlement of earnout							$ 1				1
Issuance of shares in settlement of earnout (in shares)							3,999,987
Unrealized loss on marketable securities									(61)		(61)
Stock-based compensation								1,707			1,707
Exercise of stock options								64			64
Exercise of stock options (in shares)							15,500
Exercise of warrants								22			22
Exercise of warrants (in shares)							32,279
Forfeiture of restricted stock awards (in shares)							(45,906)
Net loss										(12,046)	(12,046)
Balance at Jun. 30, 2023							$ 4	$ 312,251	$ (96)	$ (222,720)	$ 89,439
Balance (in Shares) at Jun. 30, 2023							35,743,007